Alternative treatments for people with thyroid cancer to be offered routinely on the NHS, says NICE

Alternative treatments for people with thyroid cancer to be offered routinely on the NHS, says NICE

The new guidance recommends three drugs, treating two types of thyroid cancer to be made routinely available in the NHS.

Read article

NICE announces next steps in updating its guideline on ME/CFS

NICE announces next steps in updating its guideline on ME/CFS

A workshop last month with stakeholders marked the formal start of NICE’s collaborative work to update its 2010 guideline on the diagnosis and management of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

Read article

Drug company says it will negotiate terms to allow children to access new treatment for rare genetic disorder

Drug company says it will negotiate terms to allow children to access new treatment for rare genetic disorder

NICE has published draft guidance that does not recommend the drug cerliponase alfa (also called Brineura and made by Biomarin) for children with neuronal ceroid lipofuscinosis type 2 (CLN2) – a very rare inherited condition affecting between 1 and 6 babies each year in the UK.

Read article

Once a day pill for ovarian cancer could be made available on the CDF

Once a day pill for ovarian cancer could be made available on the CDF

NICE has invited Tesaro to submit a proposal for including niraparib (Zejula) in the Cancer Drugs Fund (CDF), for treating some types of recurrent ovarian cancer.

Read article

Latest news headlines